Joint Stock Company Pharmstandard
Joint Stock Company Pharmstandard, headquartered in Russia, is a leading player in the pharmaceutical industry, specialising in the development, production, and distribution of a wide range of medicinal products. Founded in 2003, the company has established itself as a key provider of high-quality pharmaceuticals, with a strong presence in major operational regions across Russia and the CIS.
Pharmstandard's core offerings include prescription medications, over-the-counter drugs, and biopharmaceuticals, distinguished by their commitment to innovation and quality. The company has achieved significant milestones, including the introduction of several unique formulations that cater to diverse therapeutic areas. With a robust market position, Pharmstandard is recognised for its contributions to healthcare, making it a trusted name among healthcare professionals and patients alike.
-21 vs industry average
Joint Stock Company Pharmstandard’s score of 18 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Joint Stock Company Pharmstandard?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Joint Stock Company Pharmstandard yet.
Joint Stock Company Pharmstandard's reported carbon emissions
Joint Stock Company Pharmstandard, headquartered in Russia, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to reducing greenhouse gas emissions at this time.
As a current subsidiary, Pharmstandard's climate initiatives and emissions data may be influenced by its corporate family, but no specific cascading data from a parent organization has been provided. Consequently, the company appears to be in the early stages of developing a comprehensive climate strategy.
In the context of the pharmaceutical industry, where sustainability and climate action are increasingly important, Pharmstandard may need to consider setting measurable targets and participating in initiatives such as the Science Based Targets initiative (SBTi) to align with global climate goals.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Joint Stock Company Pharmstandard’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Joint Stock Company Pharmstandard yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Joint Stock Company Pharmstandard
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project